Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study
Related Posts
Johnson SF, Tabatabaei SMH, Kim GHJ, Villegas BE, Brown M, Genshaft S, Suh RD, Barjaktarevic I, Wallace WD, Abtin F. Predicting Invasiveness in Lepidic Pattern[...]
Yoshihara H, Tsugawa Y, Fukuda M, Okiyama S, Nakayama T. Detection of hypertension from pharyngeal images using deep learning algorithm in primary care settings in[...]
Todd JL, Weber JM, Kelly FL, Nagler A, McArthur P, Eason L, Rim JG, Frankel CW, Belperio JA, Budev M, Martinu T, Patel K, Reynolds[...]